Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient

被引：42

作者：

Fong, YF ^{[1
]}

Singh, K ^{[1
]}

机构：

[1] Natl Univ Hosp, Dept Obstet & Gynaecol, Singapore 119074, Singapore

来源：

CONTRACEPTION | 1999年 / 60卷 / 01期

关键词：

levonorgestrel-releasing intrauterine system; myoma; menorrhagia; renal transplant;

D O I：

10.1016/S0010-7824(99)00061-X

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

The levonorgestrel-releasing intrauterine system (LNG-IUS) has been used in the treatment of both idiopathic menorrhagia and adenomyosis. An electronic search of the on-line medical literature revealed no reports of its use for menorrhagia secondary to uterine myomas. Presented here is the successful treatment of uterine myomas with menorrhagia in a woman with a renal transplant. There was a significant reduction in menorrhagia, dysmenorrhea, and uterine and myoma size with the use of the LNG-IUS. We believe that this system provides an alternative to conventional hysterectomy and gonadotrophin-releasing hormonal analog medical treatment for uterine myomas, with a possibly inhibitory effect on myoma growth. CONTRACEPTION 1999;60:51-53 (C) 2999 Elsevier Science Inc. All rights reserved.

引用

页码：51 / 53

页数：3

共 11 条

[1] Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system [J].

Critchley, HOD ;

Wang, H ;

Kelly, RW ;

Gebbie, AE ;

Glasier, AF .

HUMAN REPRODUCTION, 1998, 13 (05) :1210-1217

[2]

DONNEZ J, 1992, CURR OPIN OBSTET GYN, V4, P439

[3] Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device [J].

Fedele, L ;

Bianchi, S ;

Raffaelli, R ;

Portuese, A ;

Dorta, M .

FERTILITY AND STERILITY, 1997, 68 (03) :426-429

[4] Expression of progesterone receptor form A and B mRNAs in uterine leiomyoma [J].

Fujimoto, J ;

Hirose, R ;

Ichigo, S ;

Sakaguchi, H ;

Li, YL ;

Tamaya, T .

TUMOR BIOLOGY, 1998, 19 (02) :126-131

[5] INSULIN-LIKE GROWTH-FACTOR (IGF), IGF BINDING-PROTEIN (IGFBP), AND IGF RECEPTOR GENE-EXPRESSION AND IGFBP SYNTHESIS IN HUMAN UTERINE LEIOMYOMATA [J].

GIUDICE, LC ;

IRWIN, JC ;

DSUPIN, BA ;

PANNIER, EM ;

JIN, IH ;

VU, TH ;

HOFFMAN, AR .

HUMAN REPRODUCTION, 1993, 8 (11) :1796-1806

[6] A COMPARISON OF FLURBIPROFEN, TRANEXAMIC ACID, AND A LEVONORGESTREL-RELEASING INTRAUTERINE CONTRACEPTIVE DEVICE IN THE TREATMENT OF IDIOPATHIC MENORRHAGIA [J].

MILSOM, I ;

ANDERSSON, K ;

ANDERSCH, B ;

RYBO, G .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (03) :879-883

[7] INTRAUTERINE PROGESTIN INDUCES CONTINUOUS INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 PRODUCTION IN THE HUMAN ENDOMETRIUM [J].

PEKONEN, F ;

NYMAN, T ;

LAHTEENMAKI, P ;

HAUKKAMAA, M ;

RUTANEN, EM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (02) :660-664

[8] PROGESTERONE - A CRITICAL ROLE IN THE PATHOGENESIS OF UTERINE MYOMAS [J].

REIN, MS ;

BARBIERI, RL ;

FRIEDMAN, AJ .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (01) :14-18

[9] mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel system [J].

Rutanen, EM ;

Salmi, A ;

Nyman, T .

MOLECULAR HUMAN REPRODUCTION, 1997, 3 (09) :749-754

[10] The effect of intrauterine levonorgestrel use on the expression of c-JUN, oestrogen receptors, progesterone receptors and Ki-67 in human endometrium [J].

Salmi, A ;

Pakarinen, P ;

Peltola, AM ;

Rutanen, EM .

MOLECULAR HUMAN REPRODUCTION, 1998, 4 (12) :1110-1115

← 1 2 →